Q1 2025 13F Holders as of 3/31/2025
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
44.5M
-
Number of holders
-
47
-
Total 13F shares, excl. options
-
24.6M
-
Shares change
-
-2.44M
-
Total reported value, excl. options
-
$30M
-
Value change
-
-$5.39M
-
Put/Call ratio
-
0
-
Number of buys
-
23
-
Number of sells
-
-25
-
Price
-
$1.22
Significant Holders of TELA Bio, Inc. - Common Stock, par value $0.001 per share (TELA) as of Q1 2025
61 filings reported holding TELA - TELA Bio, Inc. - Common Stock, par value $0.001 per share as of Q1 2025.
TELA Bio, Inc. - Common Stock, par value $0.001 per share (TELA) has 47 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 24.6M shares
of 44.5M outstanding shares and own 55.2% of the company stock.
Largest 10 shareholders include Essex Woodlands Management, Inc. (4.11M shares), Nantahala Capital Management, LLC (3.88M shares), SILVERARC CAPITAL MANAGEMENT, LLC (2.77M shares), Stonepine Capital Management, LLC (2.06M shares), VANGUARD GROUP INC (1.93M shares), DAFNA Capital Management LLC (1.44M shares), AIGH Capital Management LLC (1.42M shares), Pentwater Capital Management LP (999K shares), PERKINS CAPITAL MANAGEMENT INC (911K shares), and CITIGROUP INC (750K shares).
This table shows the top 47 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.